VRAY - ViewRay, Inc.

ViewRay, Inc.

2 Thermo Fisher Way
Oakwood, OH 44146
United States
440-703-3210
http://www.viewray.com

Sector: Healthcare
Industry: Medical Devices
Full Time Employees: 221

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Scott William Drake	Pres, CEO & Director	770.08k	N/A	1968
Mr. Shahriar Matin	Chief Operating Officer	526.46k	N/A	1975
Mr. James Alecxih	Chief Commercial Officer	315k	N/A	1965
Mr. Brian Knaley	Interim Chief Financial Officer	N/A	N/A	1970
Dr. James F. Dempsey	Chief Scientific Officer & Director	N/A	N/A	1971

Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

ViewRay, Inc. designs, manufactures, and markets radiation therapy systems. The company offers MRIdian, a magnetic resonance image-guided radiation therapy system to image and treat cancer patients. Its MRIdian integrates MRI technology, radiation delivery, and proprietary software to see the soft tissues, shape the dose to accommodate for changes in anatomy, and strike the target using real-time targeting throughout the treatment. ViewRay, Inc. serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers. The company markets its MRIdian through a direct sales force in North America. ViewRay, Inc. has collaboration agreements with Elekta AB and Medtronic. The company was founded in 2004 and is headquartered in Oakwood, Ohio.

Corporate Governance

ViewRay, Inc.’s ISS Governance QualityScore as of October 4, 2019 is 9. The pillar scores are Audit: 2; Board: 8; Shareholder Rights: 8; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.